Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Tevogen Bio Inc.

    NASDAQ: TVGN · Real-Time Price · USD
    1.24
    -0.03 (-2.36%)
    At close: Jun 13, 2025, 3:59 PM
    1.24
    -0.05%
    After-hours: Jun 13, 2025, 07:50 PM EDT

    Tevogen Bio Statistics

    Share Statistics

    Tevogen Bio has 183.89M shares outstanding. The number of shares has increased by 4.75% in one year.

    Shares Outstanding

    n/a
    		 183.89M

    Shares Change (YoY)

    n/a
    		 4.75%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 1.36%

    Shares Floating

    n/a
    		 28.38M

    Failed to Deliver (FTD) Shares

    n/a
    		 53,750

    FTD / Avg. Volume

    n/a
    		 5.64%

    Short Selling Information

    The latest short interest is 1.8M, so 0.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.8M

    Short % of Shares Out

    n/a
    		 0.98%

    Short % of Float

    n/a
    		 3.66%

    Short Ratio (days to cover)

    n/a
    		 2.89

    Valuation Ratios

    The PE ratio is -11.01 and the forward PE ratio is -5.56. Tevogen Bio's PEG ratio is 0.

    PE Ratio

    n/a
    		 -11.01

    Forward PE

    n/a
    		 -5.56

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 -22.64

    P/FCF Ratio

    n/a
    		 -12.59

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Tevogen Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.26, with a Debt / Equity ratio of -0.43.

    Current Ratio

    n/a
    		 0.26

    Quick Ratio

    n/a
    		 0.26

    Debt / Equity

    n/a
    		 -0.43

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.24

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-762,632.22

    Employee Count

    n/a
    		 18

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 49.94% in the last 52 weeks. The beta is -0.67, so Tevogen Bio's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.67

    52-Week Price Change

    n/a
    		 49.94%

    50-Day Moving Average

    n/a
    		 1.13

    200-Day Moving Average

    n/a
    		 1.16

    Relative Strength Index (RSI)

    n/a
    		 50.61

    Average Volume (20 Days)

    n/a
    		 952,206

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -53.56M

    Net Income

    n/a
    		 -13.73M

    EBITDA

    n/a
    		 -53.56M

    EBIT

    n/a
    		 -13.91M

    Earnings Per Share (EPS)

    n/a
    		 -0.09
    Full Income Statement

    Balance Sheet

    The company has 1.28M in cash and 2.89M in debt, giving a net cash position of -1.6M.

    Cash & Cash Equivalents

    n/a
    		 1.28M

    Total Debt

    n/a
    		 2.89M

    Net Cash

    n/a
    		 -1.6M

    Retained Earnings

    n/a
    		 -113.39M

    Total Assets

    n/a
    		 4.07M

    Working Capital

    n/a
    		 -5.64M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12M and capital expenditures 0, giving a free cash flow of -12M.

    Operating Cash Flow

    n/a
    		 -12M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -12M

    FCF Per Share

    n/a
    		 -0.08
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TVGN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TVGN is $10, which is 706.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $10

    Price Target Difference

    n/a
    		 706.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -59.32

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist